Zoom In IconArrows pointing outwards The direct-to-consumer health-care startup Ro launched a new free tool Tuesday to help patients determine whether their insurance covers a buzzy class of weight loss and diabetes drugs called GLP-1s. Most insurance plans cover GLP-1s when they are used to treat diabetes, so those patients can usually avoid the roughly … Read more
It was another volatile week for stocks, but Wall Street ultimately finished lower again. The market experienced a sharp sell-off Monday on recession concerns, which led the S & P 500 and Dow Jones Industrial Average to its worst single-day performances since 2022. The VIX index — Wall Street’s fear gauge and a measure of … Read more
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Mixed Markets: The S & P 500 is trying to finish the week out on a higher note after fluctuating between gains and losses for a … Read more
CNBC’s Jim Cramer on Thursday recommended that investors not base portfolio decisions solely off macroeconomic trends, like new employment data or interest rates. “I don’t want to be bound by the four walls of the PMIs, the PPIs, the PCDEs, the GDPs. We don’t want ETFs where we buy the bad along with the good, and … Read more
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets rally: Markets on Thursday are trying to rally again after a vicious midday reversal in the prior session. The nearly 3% gain for the tech-heavy … Read more
The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, on Sept. 17, 2020. Mike Blake | Reuters Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion as sales of its blockbuster diabetes drug Mounjaro and … Read more
Stocks had a rough week, topped off with a pummeling Friday after the July jobs data came in weaker than expected. The Nasdaq led the way down, losing 3.35% on the week, followed by the Dow Jones Industrial’s decline of 2.1%, and the S & P 500’s 2.06% drop. It was a dramatic shift in … Read more
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Forceful sell-off: Wall Street was getting slammed in Friday afternoon trading, with the Dow Jones Industrial Average down more than 750 points, or 1.9%. The S … Read more
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, Dec. 11, 2023. Brendan McDermid | Reuters All doses of Eli Lilly’s highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the U.S., according to an update on the Food and Drug Administration’s drug … Read more
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. Stocks moved higher Thursday, extending Wednesday’s rally following comments from the Federal Reserve that hinted at a possible interest rate cut in September. The market also benefited from Meta ‘s … Read more
